e-learning
resources
Virtual 2021
05.09.2021
Novelties in interventional pulmonology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vivo PS-OCT to detect fibrotic lung disease
M. Vaselli (Amsterdam, Netherlands), K. Mooij - Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands), J. De Boer (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands)
Source:
Virtual Congress 2021 – Novelties in interventional pulmonology
Session:
Novelties in interventional pulmonology
Session type:
Oral Presentation
Number:
234
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Vaselli (Amsterdam, Netherlands), K. Mooij - Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands), J. De Boer (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands). In vivo PS-OCT to detect fibrotic lung disease. 234
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
Case-based imaging of connective tissue disease-related lung disease
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021
Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases.
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018
Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020
In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography
Source: Eur Respir J 2011; 38: 1060-1070
Year: 2011
Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Probe-based confocal laser-endomicroscopy imaging of differential auto-fluorescence of alveolar macrophages in diffuse lung diseases
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
Unravelling specific mechanisms of wound healing and pulmonary fibrosis in human ex vivo lung tissue slices
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020
Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept